c-Abl tyrosine kinase regulates cardiac growth and development
Open Access
- 28 December 2009
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (3) , 1136-1141
Abstract
The c-Abl protein is a ubiquitously expressed nonreceptor tyrosine kinase involved in the development and function of many mammalian organ systems, including the immune system and bone. Here we show that homozygous Abl mutant embryos and newborns on the C57BL/6J background, but not on other backgrounds, display dramatically enlarged hearts and die perinatally. The heart defects can be largely rescued by cardiomyocyte-specific restoration of the full-length c-Abl protein. The cardiac hyperplasia phenotype is not caused by decreased apoptosis, but rather by abnormally increased cardiomyocyte proliferation during later stages of embryogenesis. Genes involved in cardiac stress and remodeling and cell cycle regulation are also up-regulated in the mutant hearts. These findings reveal an essential role for c-Abl in mammalian heart growth and development.Keywords
This publication has 32 references indexed in Scilit:
- Abl tyrosine kinases in T‐cell signalingImmunological Reviews, 2009
- The effects of imatinib on pregnancy outcomeBlood, 2008
- Activated c-Abl tyrosine kinase in malignant solid tumorsOncogene, 2008
- The enigmatic role of the ankyrin repeat domain 1 gene in heart development and diseaseThe International Journal of Developmental Biology, 2008
- Cardiac Myocyte Cell Cycle Control in Development, Disease, and RegenerationPhysiological Reviews, 2007
- Guidance of myocardial patterning in cardiac development by Sema6D reverse signallingNature Cell Biology, 2004
- Insulin-Like Growth Factor-Binding Protein-3 Induces Fetalization in Neonatal Rat CardiomyocytesDNA and Cell Biology, 2000
- Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.Journal of Clinical Investigation, 1997
- Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populationsCell, 1991
- Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogeneCell, 1991